HTA95 Predicting Evidence Requirement Implications of the EU Joint Clinical Assessment (JCA) Through a Population, Comparator, Intervention, Outcome (PICO) Simulation for Two Anticancer Investigational Medicinal Products (IMPs)
Abstract
Authors
E Anastasaki N Despiegel F Dirnberger A van Engen I Majer C Oswald P Szawara R Takundwa S Ubi